Font size
- 1 2 3 + Font size

click to adjust

Page tools
Search
. Advanced search

A Targeted Approach to HealthCare

Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.

For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in health care.


Bayer News Releases


16 May 2013
Bayer to Present New Data Across Oncology Portfolio at ASCO 2013

15 May 2013
Bayer Receives U.S. FDA Approval for Xofigo® (radium Ra 223 dichloride) Injection as a New Treatment for Castration-Resistant Prostate Cancer with Bone Metastases

15 May 2013
Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Advanced Liver Cancer

8 May 2013
Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc.

8 May 2013
BAYER TO PRESENT DATA ON INVESTIGATIONAL PULMONARY HYPERTENSION COMPOUND RIOCIGUAT AT ATS 2013

29 April 2013
Bayer to acquire Conceptus, Inc.

16 April 2013
Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551) in Mechanically Ventilated Patients with Gram-negative Pneumonia

 

Press Release Archive

 


http://pharma.bayer.com/scripts/pages/en/index.php/news_room/news_room/news_room/news_room/news_room111.php

Copyright © Bayer Healthcare Pharmaceuticals